Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Pays

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Kidney International|May 21, 2015
Sequencing rare and common APOL1 coding variants to determine kidney disease riskSophie Limou, George W Nelson, Laurence Lecordier, et al.
Plos Pathogens|June 24, 2011
High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosisBenoît Stijlemans, Guy Caljon, Senthil Kumar A Natesan, et al.
Plos Neglected Tropical Diseases|September 27, 2013
Atypical human infections by animal trypanosomesPhilippe Truc, Philippe Büscher, Gérard Cuny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2017
<i>Trypanosoma musculi</i> Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a <i>Tb</i>KHC1 Kinesin H Chain HomologRomaric Nzoumbou-Boko, Géraldine De Muylder, Silla Semballa, et al.
Nature|March 7, 2003
Apolipoprotein L-I is the trypanosome lytic factor of human serumLuc Vanhamme, Françoise Paturiaux-Hanocq, Philippe Poelvoorde, et al.
Molecular and Biochemical Parasitology|April 11, 2015
Resistance to normal human serum reveals Trypanosoma lewisi as an underestimated human pathogenZhao-Rong Lun, Yan-Zi Wen, Pierrick Uzureau, et al.
Science (New York, N.Y.)|June 16, 2012
Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the hostDidier Salmon, Gilles Vanwalleghem, Yannick Morias, et al.
Iscience|September 5, 2020
The <i>Trypanosoma Brucei</i> KIFC1 Kinesin Ensures the Fast Antibody Clearance Required for Parasite InfectivityLaurence Lecordier, Sophie Uzureau, Gilles Vanwalleghem, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Nature|August 23, 2013
Mechanism of Trypanosoma brucei gambiense resistance to human serumPierrick Uzureau, Sophie Uzureau, Laurence Lecordier, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Kidney International|May 21, 2015
Sequencing rare and common APOL1 coding variants to determine kidney disease riskSophie Limou, George W Nelson, Laurence Lecordier, et al.
Plos Pathogens|June 24, 2011
High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosisBenoît Stijlemans, Guy Caljon, Senthil Kumar A Natesan, et al.
Plos Neglected Tropical Diseases|September 27, 2013
Atypical human infections by animal trypanosomesPhilippe Truc, Philippe Büscher, Gérard Cuny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2017
<i>Trypanosoma musculi</i> Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a <i>Tb</i>KHC1 Kinesin H Chain HomologRomaric Nzoumbou-Boko, Géraldine De Muylder, Silla Semballa, et al.
Nature|March 7, 2003
Apolipoprotein L-I is the trypanosome lytic factor of human serumLuc Vanhamme, Françoise Paturiaux-Hanocq, Philippe Poelvoorde, et al.
Molecular and Biochemical Parasitology|April 11, 2015
Resistance to normal human serum reveals Trypanosoma lewisi as an underestimated human pathogenZhao-Rong Lun, Yan-Zi Wen, Pierrick Uzureau, et al.
Science (New York, N.Y.)|June 16, 2012
Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the hostDidier Salmon, Gilles Vanwalleghem, Yannick Morias, et al.
Iscience|September 5, 2020
The <i>Trypanosoma Brucei</i> KIFC1 Kinesin Ensures the Fast Antibody Clearance Required for Parasite InfectivityLaurence Lecordier, Sophie Uzureau, Gilles Vanwalleghem, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Nature|August 23, 2013
Mechanism of Trypanosoma brucei gambiense resistance to human serumPierrick Uzureau, Sophie Uzureau, Laurence Lecordier, et al.
Pageof 8